James Peyer, Director, 10% Owner at Sensei Biotherapeutics, Inc. (SNSE), bought 22,576 shares at $5.28 ($119K) on 2021-12-28, disclosed to the SEC on 2021-12-29.
Open-market purchase of $119k SNSE by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.28 | 11,288 | $60K | 50.0% |
| 2 | $5.28 | 11,288 | $60K | 50.0% |
| Total | $5.28 avg | 22,576 | $119K | 100% |
| Filing → |
| SNSE | SELL | 2025-12-08 | $398K | — | Filing → |
| SNSE | BUY | 2022-04-21 | $15K | — | Filing → |
| SNSE | BUY | 2022-04-21 | $136K | — | Filing → |